Solingen, Germany

Erich Brendel


 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Erich Brendel: Innovator in Pharmaceutical Formulations

Introduction

Erich Brendel is a notable inventor based in Solingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of three patents to his name, Brendel's work focuses on enhancing the efficacy and delivery of medications.

Latest Patents

One of Brendel's latest patents is titled "Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic." This invention relates to a pharmaceutical dosage form that combines nifedipine or nisoldipine with an angiotensin II antagonist and/or a diuretic. The formulation is characterized by a controlled release of nifedipine or nisoldipine, while the other active ingredients are released rapidly, making it suitable for various medical applications.

Another significant patent is "Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same." This invention focuses on orally administrable multiple-unit sustained-release dosage forms that ensure controlled release of active compounds. The preparation utilizes a selected erodable hydrophilic polymer and limits the size of the active compound-containing polymer particles to a maximum of 3 mm.

Career Highlights

Throughout his career, Erich Brendel has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and patent development.

Collaborations

Brendel has collaborated with notable professionals in his field, including Claus Weisemann and Ernst Chantraine. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical science.

Conclusion

Erich Brendel's contributions to pharmaceutical innovations demonstrate his commitment to improving medication delivery systems. His patents reflect a deep understanding of drug formulation and release mechanisms, making him a valuable figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…